A healthy 26-year-old woman was noted to have residual uterine inversion after manual replacement of puerperal uterine inversion under general anaesthesia. This was corrected by the insertion of a balloon tamponade device. A cervical suture was applied to prevent ballooning of the device through the cervix. This little modification was immediately successful in preventing ballooning of the tamponade device. The whole idea was to overcome the need for a laparotomy. A review of the literature and the mechanism of action are discussed here.

Milenkovic M, Kahn J: Inversion of the uterus: a serious complication at childbirth. Acta Obstet Gynecol Scand 2005;84:95-96.
Calder AA: Emergencies in operative obstetrics. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:43-55.
Wendel PJ, Cox SM: Emergent obstetric management of uterine inversion. Obstet Gynecol Clin North Am 1995;22:261-274.
Shah-Hosseini R, Evrard JR: Puerperal uterine inversion. Obstet Gynecol 1989;73:567-570.
Achanna S, Mohamed Z, Krishnan M: Puerperal uterine inversion: a report of four cases. J Obstet Gynaecol Res 2006;32:341-345.
Occhionero M, Restaino G, Ciuffreda M, Carbone A, Sallustio G, Ferrandina G: Uterine inversion in association with uterine sarcoma: a case report with MRI findings and review of the literature. Gynecol Obstet Invest 2012;73:260-264.
Beringer RM, Patteril M: Puerperal uterine inversion and shock. Br J Anaesth 2004;92:439-441.
O'Sullivan JV: Acute inversion of the uterus. Br Med J 1945;2:282-283.
Johnson AB: A new concept in the replacement of the inverted uterus and a report of nine cases. Am J Obstet Gynecol 1949;57:557-562.
Thomson AJ, Greer IA: Non-haemorrhagic obstetric shock. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:19-41.
Livingston SL, Booker C, Kramer P, Dodson WC: Chronic uterine inversion at 14 weeks postpartum. Obstet Gynecol 2007;109(2 Pt 2):555-557.
Garrett-Albaugh S, Stitely ML, Millan L, Hochberg C: Chronic postpartum uterine inversion treated by abdominal replacement and cerclage. W V Med J 2011;107:43-45.
Tank Parikshit D, Mayadeo Niranjan M, Nandanwar YS: Pregnancy outcome after operative correction of puerperal uterine inversion. Arch Gynecol Obstet 2004;269:214-216.
Bakri YN, Amri A, Abdul Jabbar F: Tamponade-balloon for obstetrical bleeding. Int J Gynaecol Obstet 2001;74:139-142.
Ghirardini G, Alboni C, Mabrouk M: Use of balloon tamponade in management of severe vaginal postpartum hemorrhage and vaginal hematoma: a case series. Gynecol Obstet Invest 2012;74:320-323.
Condous GS, Arulkumaran S, Symonds I, Chapman R, Sinha A, Razvi K: The ‘tamponade test' in the management of massive postpartum hemorrhage. Obstet Gynecol 2003;101:767-772.
Postpartum Haemorrhage, Prevention and Management (Green-Top Guideline No. 52). London, RCOG, 2009.
Cho Y, Rizvi C, Uppal T, Condous G: Ultrasonographic visualization of balloon placement for uterine tamponade in massive primary postpartum hemorrhage. Ultrasound Obstet Gynecol 2008;32:711-713.
Kawamura A, Kondoh E, Hamanishi J, Kawamura Y, Kusaka K, Ueda A, et al: Cervical clamp with ring forceps to prevent prolapse of an intrauterine balloon in the management of postpartum hemorrhage. J Obstet Gynaecol Res 2013;39:733-737.
Kaya B, Tüten A, Çelik H, Mısırlıoğlu M, Unal O: Non-invasive management of acute recurrent puerperal uterine inversion with Bakri postpartum balloon. Arch Gynecol Obstet 2014;289:695-696.
Soleymani Majd H, Pilsniak A, Reginald PW: Recurrent uterine inversion: a novel treatment approach using SOS Bakri balloon. BJOG 2009;116:999-1001.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.